| Analysis | Metabolite Name | Measured Value | Units | Construct |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (2M-H)- | 3003 | Peak area | Control lentivirus |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (2M-H)- | Peak area | Control lentivirus | |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (2M-H)- | Peak area | Noxa knockdown | |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 54545 | Peak area | Control lentivirus |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 234258 | Peak area | Noxa knockdown |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 254005 | Peak area | Noxa knockdown |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 263905 | Peak area | Noxa knockdown |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 290162 | Peak area | Control lentivirus |
| Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 305175 | Peak area | Control lentivirus |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|